Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters

References

• Cochran G, Woo B, Lo-Ciganic W, Gordon AJ, Donohue JM, Gellad W. Defining non-medical use of prescription opioids within health care claims: a systematic review. Subst Abus. 2015;36:192–202.
   PubMed Web of Science ®Google Scholar
• Cochran G, Bacci J, Ylioja T, et al. Prescription opioid use: patient characteristics and misuse in community pharmacy. J Am Pharm Assoc. 2016;56(3):248–256.
   Google Scholar
• Martineau F, Tyner E, Lorenc T, Petticrew T, Lock K. Population-level interventions to reduce alcohol-related harm: an overview of systematic reviews. Prev Med. 2013;57;278–296.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Baler RD, Comptom W.M, Weiss SRB. Adverse health effects of marijuana use. New Engl J Med. 2014;370:2219–2227.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM, Evins EA, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73:292–297.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results From the 2014 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-50. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS Publication No. SMA 15–4927. http://www.samhsa.gov/data/. October 24, 2016.
   Google Scholar
• Kertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017;38:3–8.
   PubMed Web of Science ®Google Scholar
• Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated healthcare system. J Addict Med. 2017;11:3–9.
   PubMed Web of Science ®Google Scholar
• McCabe CT, Woodruff SI, Zuniga MI. Sociodemographic and substance use correlates of tobacco use in a large, multi-ethnic sample of emergency department patients. Addict Behav. 2011;36:899–905.
   PubMed Web of Science ®Google Scholar
• Wu L, Swartz MS, Wu Z., Mannelli P., Yang C., Biazer D. Alcohol and drug use disorders among adults in emergency department settings in the United States. Ann Emerg Med. 2012;60:172–185.
   PubMed Web of Science ®Google Scholar
• Cherpitel CJ, Yu Y. Trends in alcohol- and drug-related emergency department and primary care visits: data from four U.S. national surveys (1995–2010). J Stud Alcohol Drugs. 2012;73:454–458.
   PubMed Web of Science ®Google Scholar
• Frank JW, Binswanger IA, Calcaterra SL, Brenner LA. Non-medical use of prescription pain medication and increased emergency department utilization: results of a national survey. Drug Alcohol Depend. 2015;157:150–157.
   PubMed Web of Science ®Google Scholar
• Rockett L.R.H, Putnam SL, Jia H, Smith GS. Declared and undeclared substance use among emergency department patients: a population based study. Addiction. 2006;101:706–712.
   PubMed Web of Science ®Google Scholar
• Sanjuan PM, Rice SL, Witkiewitz K, et al. Alcohol, tobacco, and drug use among emergency department patients. Drug Alcohol Depend. 2014;138;32–38.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Sarvet AL, Cerda M et al. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws 1991–1992 to 2012–2013. JAMA Psychiatry 2017;74(6):579–588.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Saha T, Bradley T et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72:1235–1242.
   PubMed Web of Science ®Google Scholar
• Ray GT, Weisner CM, Mertens JR. Relationship between use of psychiatric services and five-year alcohol and drug use treatment outcomes. Psychiatr Serv. 2005;56:164–171.
   PubMed Web of Science ®Google Scholar
• Charlson M, Charlson R, Peterson J, Marinopoulos S, Briggs W, Hollenberg J. The Charlson Comorbidity Index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234–1240.
   PubMed Web of Science ®Google Scholar
• Raudenbush DSW, Bryk DAS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage; 2009.
   Google Scholar
• R Development Core Team. R: a language and environment for statistical computing [computer software]. Version 3.3.1. Vienna, Austria: R Foundation for Statistical Computing; 2016
   Google Scholar
• Schukit M. Alcohol-use disorders. Lancet. 2009;373:493–501.
   Web of Science ®Google Scholar
• Edlund M, Steffick D, Hudson T, Harris K, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129:355–362.
   PubMed Web of Science ®Google Scholar
• Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–1391.
   PubMed Web of Science ®Google Scholar
• Calcaterra S, Glanz J, Binswanger I. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–270.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The NSDUH Report: Substance Use and Mental Health Estimates From the 2013 National Survey on Drug Use and Health: Overview of Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014, September 4.
   Google Scholar
• Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry. 2016;175:18–26.
   Web of Science ®Google Scholar
• Onofrio GD, Chawarski MC, O'Connor PG, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32(2):660–666.
   PubMedGoogle Scholar
• Hasin DS, Saba TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012 and 2012–2013. JAMA Psychiatry. 2015;72:1235–1242.
   PubMed Web of Science ®Google Scholar
• Chi FW, Parthasarathy S, Mertens JR, Weisner CW. Continuing care and long-term substance use outcomes in managed care: early evidence for a primary care-based model. Psychiatr Serv. 2011;62:1194–1200.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Chi FW, Mertens JR, Weisner CW. The role of continuing care in 9-year cost trajectories of patients with intakes into an outpatient alcohol and drug treatment program. Med Care. 2012;50:540–546.
   PubMed Web of Science ®Google Scholar
• Macy TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and correlates of prescription of opioid use in OEF/OIF veterans with chronic noncancer pain. Pain Med. 2011;12:1502–1509.
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CI. A model to identify patients at risk for prescription opioid abuse, dependence and misuse. Pain Med. 2012;13:1162–1173.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440–449.
   PubMed Web of Science ®Google Scholar
• Ray GT, Mertens JR, Weisner C. Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma. Addiction. 2009;104:203–214.
   PubMed Web of Science ®Google Scholar
• Young JQ, Kine-Simon AH, Mordecai DJ, Weisner CM. Prevalence of behavioral health disorders and associated chronic disease burden in a commercially insured health system: findings of a case-control study. Gen Hosp Psychiatry. 2015;37:101–108.
   PubMed Web of Science ®Google Scholar